George Farmer
Stock Analyst at Scotiabank
(2.16)
# 2,871
Out of 5,140 analysts
70
Total ratings
44.74%
Success rate
-2.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Maintains: Sector Outperform | $30 → $10 | $1.41 | +609.22% | 4 | Aug 6, 2025 | |
| ACLX Arcellx | Maintains: Sector Outperform | $93 → $133 | $68.87 | +93.12% | 4 | Jul 31, 2025 | |
| INMB INmune Bio | Downgrades: Sector Underperform | $23 → $0.6 | $1.64 | -63.41% | 3 | Jul 1, 2025 | |
| URGN UroGen Pharma | Maintains: Sector Outperform | $23 → $47 | $19.23 | +144.41% | 1 | Jun 13, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $20.52 | -17.15% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $5.77 | +107.97% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $2.61 | +244.83% | 4 | Apr 10, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $13.27 | +208.97% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $33.94 | +53.21% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $56.77 | +40.92% | 8 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $244 → $224 | $172.62 | +29.76% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $102 | $33.38 | +205.57% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $8.72 | +14.68% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $816.37 | -12.42% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $5.48 | +319.71% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $0.98 | +1,939.57% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $20.76 | +266.09% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $3.02 | +330.46% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $49.81 | +118.83% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $104.67 | -16.88% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $2.12 | +1,456.60% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $0.66 | +5,967.04% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $44.81 | -39.75% | 3 | May 6, 2020 |
Biomea Fusion
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $30 → $10
Current: $1.41
Upside: +609.22%
Arcellx
Jul 31, 2025
Maintains: Sector Outperform
Price Target: $93 → $133
Current: $68.87
Upside: +93.12%
INmune Bio
Jul 1, 2025
Downgrades: Sector Underperform
Price Target: $23 → $0.6
Current: $1.64
Upside: -63.41%
UroGen Pharma
Jun 13, 2025
Maintains: Sector Outperform
Price Target: $23 → $47
Current: $19.23
Upside: +144.41%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $20.52
Upside: -17.15%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $5.77
Upside: +107.97%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $2.61
Upside: +244.83%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $13.27
Upside: +208.97%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $33.94
Upside: +53.21%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $56.77
Upside: +40.92%
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $172.62
Upside: +29.76%
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $33.38
Upside: +205.57%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $8.72
Upside: +14.68%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $816.37
Upside: -12.42%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $5.48
Upside: +319.71%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $0.98
Upside: +1,939.57%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $20.76
Upside: +266.09%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $3.02
Upside: +330.46%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $49.81
Upside: +118.83%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $104.67
Upside: -16.88%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $2.12
Upside: +1,456.60%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $0.66
Upside: +5,967.04%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $44.81
Upside: -39.75%